- Tytuł:
- A clinical phase II study with sorafenib in patients with progressive hormone-refractory prostate cancer: a study of the CESAR Central European Society for Anticancer Drug Research-EWIV.
- Autorzy:
- Źródło:
- British Journal of Cancer. 12/3/2007, Vol. 97 Issue 11, p1480-1485. 6p. 3 Charts, 2 Graphs.
Czasopismo naukowe